Media Centre BlogAugust 29, 2023Genetic Signatures Announces Strategic Channel Partnership with Almog Diagnostic for Market Entry into IsraelBlogAugust 22, 2023Genetic Signatures Announces Strategic Partnership with Integrated Gulf Biosystems for Expanded Market Reach in the Middle EastBlogJuly 21, 2022A trusted partnership to support reliable, high throughput PCR testing for COVID-19 in GermanyBlogJuly 14, 2022Omicron BA.4 and BA.5 SubvariantsBlogDecember 17, 20213base Technology and Reliable Detection of SARS-CoV-2 VariantsBlogNovember 29, 2021The EasyScreen™ SARS-CoV-2 Detection Kit has a 100% match by in silico analysis to the new Omicron variant of the SARS-CoV-2 virus and will efficiently detect the new variant.BlogNovember 21, 2022World Antimicrobial Awareness Week 2022: Preventing Antimicrobial Resistance Together
BlogAugust 29, 2023Genetic Signatures Announces Strategic Channel Partnership with Almog Diagnostic for Market Entry into Israel
BlogAugust 22, 2023Genetic Signatures Announces Strategic Partnership with Integrated Gulf Biosystems for Expanded Market Reach in the Middle East
BlogJuly 21, 2022A trusted partnership to support reliable, high throughput PCR testing for COVID-19 in Germany
BlogNovember 29, 2021The EasyScreen™ SARS-CoV-2 Detection Kit has a 100% match by in silico analysis to the new Omicron variant of the SARS-CoV-2 virus and will efficiently detect the new variant.
BlogNovember 21, 2022World Antimicrobial Awareness Week 2022: Preventing Antimicrobial Resistance Together
